Adam Townsend

Insider Reports History

Entity
Individual
Location
C/O Apellis Pharmaceuticals, Inc., 6400 Westwind Way, Suite A, Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Adam Townsend
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Townsend:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 92.5K $6.27M $67.77 Feb 12, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Commercial Officer Stock Option (Right to Buy) 34.5K $2.29M $66.30 Jan 16, 2024 Direct

Insider Reports Filed by Adam Townsend

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Feb 12, 2024 1 -$77.8K 4 Feb 13, 2024 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$58.1K 4 Jan 31, 2024 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$222K 4 Jan 23, 2024 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $2.14M 4 Jan 17, 2024 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Dec 1, 2023 4 -$5.03M 4 Dec 5, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. May 3, 2023 3 -$338K 4 May 4, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Apr 3, 2023 3 -$295K 4 Apr 5, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Mar 3, 2023 3 -$244K 4 Mar 7, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$60.9K 4 Feb 22, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2023 1 -$40K 4 Feb 14, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 3, 2023 3 -$204K 4 Feb 6, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$29.1K 4 Jan 30, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$99.5K 4 Jan 24, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 12, 2023 2 $2.27M 4 Jan 17, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 3, 2023 3 -$178K 4 Jan 5, 2023 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Dec 5, 2022 3 -$327K 4 Dec 7, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Nov 3, 2022 3 -$368K 4 Nov 7, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Oct 3, 2022 3 -$258K 4 Oct 5, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Sep 6, 2022 3 -$226K 4 Sep 7, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Aug 15, 2022 3 -$674K 4 Aug 16, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Aug 11, 2022 3 -$649K 4 Aug 12, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Aug 8, 2022 3 -$624K 4 Aug 9, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Aug 3, 2022 3 -$207K 4 Aug 4, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Apr 21, 2022 5 -$167K 4 Jul 12, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 1 -$42.2K 4 Feb 14, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$30.9K 4 Feb 1, 2022 Chief Commercial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Chief Commercial Officer